Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,291 | -491 | -2,026 | -1,247 | -829 |
| Depreciation Amortization | 1 | 1 | 2 | 2 | 1 |
| Accounts payable and accrued liabilities | -51 | -138 | 178 | 111 | 78 |
| Other Working Capital | -24 | -144 | 439 | 9 | 227 |
| Other Operating Activity | 653 | 285 | 261 | 216 | 83 |
| Operating Cash Flow | $-711 | $-487 | $-1,145 | $-909 | $-441 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 415 | 160 | 325 | 325 | 200 |
| Common Stock Issued | 375 | 275 | 776 | 526 | 201 |
| Other Financing Activity | 0 | 0 | -43 | -43 | -43 |
| Financing Cash Flow | $790 | $435 | $1,058 | $808 | $358 |
| Exchange Rate Effect | -7 | 95 | 23 | 48 | 37 |
| Beginning Cash Position | 2 | 2 | 67 | 67 | 67 |
| End Cash Position | 74 | 46 | 2 | 14 | 21 |
| Net Cash Flow | $71 | $44 | $-65 | $-53 | $-46 |
| Free Cash Flow | |||||
| Operating Cash Flow | -711 | -487 | -1,145 | -909 | -441 |
| Free Cash Flow | -711 | -487 | -1,145 | -909 | -441 |